Urology Times names three to Editorial Council

Article

Urology Times has appointed three expert urologists to its Editorial Council.

Urology Times has appointed three expert urologists to its Editorial Council: Jeffrey E. Kaufman, MD, Arthur L. Burnett, II, MD, MBA, and Barry A. Kogan, MD.

Read: Upfront chemo called ‘standard’ in hormone-naïve PCa

Dr. Kaufman, a private practitioner in Santa Ana, CA, will represent the area of health policy/socioeconomics. Dr. Burnett, professor of urology at Johns Hopkins Medicine, Baltimore, will oversee our coverage of sexual dysfunction. Dr. Kogan, chief of urology at Albany Medical Center, Albany, NY, will serve as our expert in pediatric urology.

“I expect the knowledge base and leadership that Drs. Kaufman, Burnett, and Kogan bring to the field will help Urology Times maintain its position as the top-read urology publication in the United States,” said Richard R. Kerr, Urology Times’ content channel director. “We are honored to have them in our fold.”

Urology Times also extends its gratitude and appreciation to William F. Gee, MD, John J. Mulcahy, MD, PhD, Howard M. Snyder, III, MD, and Anthony J. Schaeffer, MD, who recently stepped down from the Editorial Council after many years of dedicated, loyal service.

Have you read:

Overactive bladder: Two drugs found better than one

Metformin/statin combo therapy reduces PCa mortality

Despite warnings, mesh use for prolapse on the rise

To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.